Naveen Kumar Kotla

Naveen Kumar Kotla

Auto-generated profile, based on publicly available information

Naveen Kumar Kotla

Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja Subodh Chandra Mullick Road, Kolkata, 700032 West Bengal, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2019 in ACS Omega
Verified
Journal Article
Open access
AMAyan Mukherjee
Ayan Mukherjee
SMSnehasis Mishra
Snehasis Mishra
NKNaveen Kumar Kotla
Naveen Kumar Kotla
KMKrishnendu Manna
Krishnendu Manna
SRSwarnali Roy
Swarnali Roy
ATArindam Talukdar
Arindam Talukdar
Quercetin has been found to possess diverse pharmacological properties including in different types of cancers. The application of quercetin in the pharmaceutical field is limited due to its poor bioavailability resulting from poor water solubility and poor permeability. We report a systematic chemical modification of quercetin toward the development of semisynthetic derivatives through a selective synthetic methodology, which enables the installation of different substitutions at C-3′ and C-5 positions of quercetin. The hypothesis of the present manuscript was to modulate the log D value and aqueous solubility of quercetin through the attachment of some facilitator moieties. The semisynthetic derivatives with an ideal log D value and improved aqueous solubility will possess a better cell-penetrating ability compared to quercetin. Representative compound 17 shows 96-fold increase in the cytotoxic activity in HCT-116 colon cancer cells as compared to quercetin. The in vivo treatment of 17 in CT-26 tumor-bearing mice in a colon cancer model resulted in a striking increase in the survival rate and reduction in tumor weight (60%) with respect to quercetin. We believe that the current study has an immense potential toward the systemic development of clinically approved quercetin semisynthetic derivatives.